Introduction
============

*Enterococcus faecalis* is one of the main nosocomial pathogens ([@B13]) which may be resistant to a wide range of antimicrobial agents, causing several diseases. These bacteria inhabit the gastrointestinal and genitourinary tracts and have been related to infectious endocarditis and surgical wound infection ([@B26]). In the oral cavity, *E. faecalis* is likely to be found in caries lesions, in periodontal diseases ([@B33]), and mainly in endodontic infections ([@B09], [@B06]), in which pulp may become infected via dentinal tubules, through carious lesions, and via periodontal disease. Studies have shown that remaining *E. faecalis* contributes to the failure of endodontic therapy. The suppression and control of *E. faecalis* in dental procedures is paramount to diminish invasion of bacteria in dentinal tubules ([@B20]), as well as to avoid strains to get resistance to several antibiotics ([@B02]) and irrigating solutions, to avoid bacteria adaptation to environments where nutrients are scarce, and to abolish the establishment of any relationship with other bacteria, as in biofilms, environment and virulence factors ([@B16]).

Chemical and mechanical site preparation in the treatment of caries lesions and periodontal and endodontic infections aim to reduce infection and provide a favorable environment for an effective treatment. Chemical preparation in endodontics is synonym of sodium hypochloride (SH). Currently, there is a limited number of irrigating substances with antimicrobial properties that can be used in periodontal and endodontic treatment, as well as in the treatment of carious lesions. Most of the chemical substances show adverse factors, such as toxicity, non-physiological pH, unpleasant odor and taste, and inability to degrade organic matter and smear layer. One of the most widely indicated substance is SH diluted to 1% ([@B07]).

The use of SH as irrigation solution is part of the protocols established to prepare root canals to endodontic treatments, considering that removal of any microorganism is fundamental to avoid any further relapse. One of the main microorganisms found in recurrent failure in endodontic treatment is *E. faecalis*, which is a bacterium that exhibits increased virulence in pathological conditions of endodontic disease. For that reason, this bacterium is one of the main target for drug action in the treatment of this oral pathological condition ([@B30]; [@B29]). Considering the undesirable effects related to SH, it has become increasingly necessary to find new tools to assist in the fight against *E. faecalis*.

Systematic studies with plant and animal extracts ([@B01]) have shown that it is possible to find compounds with pharmaceutical potential, such as some antibacterial chemotherapeutic agents (penicillin, erythromycin, tetracyclin). Universidade Paulista (UNIP), Brazil, introduced in 1996 a large-scale bioprospecting program targeting the identification of antibacterial compounds in plant extracts native to Brazilian forests. Throughout the program, over 2,000 plant extracts were tested against several microorganisms, such as *Staphylococcus aureus, Escherichia coli*, *Pseudomonas aeruginosa*, *Candida albicans*, *Streptococcus mutans*, *S. sanguinis*, and *Enterococcus faecalis* ([@B37]; [@B38]; [@B36]; [@B35]). Based on these results, the present study aimed the study of the antibacterial activity of 25 plant extracts and their residues against traditional antibacterial assays and to search for chemical groups that may occur in the active extracts and residues, emphasizing an organic extract obtained from *Symphonia globulifera*, which was available in higher amounts to develop initial chemical studies.

Material and Methods
====================

Plant collection and extraction preparation
-------------------------------------------

For plant collection and extraction, our team obtained a collecting permit issued by the Brazilian Institute of Environment and Renewable Natural Resources - IBAMA and a permit to access genetic resources issued by the Genetic Heritage Management Council - CGen of the Brazilian Ministry of the Environment. Collected plants were taxonomically identified and voucher specimens were deposited at UNIP Herbarium, São Paulo, Brazil. Organic and aqueous extracts were obtained by a 24-h maceration with dichloromethane: methanol (1:1), followed by a 24-h maceration with distilled water (Millipore^®^, Bedford, MA, USA) ([@B40]; [@B41]).

Test compounds and controls
---------------------------

Twenty-five previously selected extracts, here designed as EB 55, EB 321, EB 352, EB 429, EB 841, EB 1247, EB 1257, EB 1259, EB 1298, EB 1373, EB 1389, EB 1395, EB 1461, EB 1493, EB 1497, EB 1525, EB 1543, EB 1549, EB 1637, EB 1743, EB 1765, EB 1905, EB 1923, EB 1991 and EB 1999, which taxonomical and collection data are listed in [table 1](#t01){ref-type="table"}, were diluted to a series of dilutions that led to final test concentrations in the microdilution broth assay of 12,500, 10,000, 7,500, 5,000, 2,500, 1,300, 600, 310, 160, 80, and 40 μg/mL*,*, being 20 times more diluted than the initial extracts dilutions, according to the established protocol). Dimethylsulfoxide and water were used as solvent in the dilution procedure. Sodium hypochlorite 1% (SH) was used as positive control, and was obtained from a formulated SH 10% solution (Fórmula & Ação - Compounding Pharmacy). A 1% SH commercial solution (Asfer^®^, São Paulo, SP, Brazil) was also used as positive control. The same extracts were tested in disk diffusion assay at a concentration of 200 mg/mL, diluted in dimethylsulfoxide 50% in water. All organic extracts were diluted in dimethylsulfoxide 50% (DMSO50).

###### 

List of extracts showing activity against *Enterococcus faecalis* ATCC^®^ 29212™ and the corresponding minimal inhibitory concentrations obtained from microdilution broth assay.

  Extract number[\*](#tfn01){ref-type="table-fn"}   Herbarium reference   Collect date   Organ                Family                      Gender              Species                    1 × 10^5^ cfu MIC (μg/mL)
  ------------------------------------------------- --------------------- -------------- -------------------- --------------------------- ------------------- -------------------------- ---------------------------
  55                                                PSC 396               05/12/1997     Leaves               Fabaceae Caesalpinioideae   *Macrolobium*       *multijugum*               5,000 \< MIC \< 12,500
  321                                               PSC 414               06/12/1997     Leaves and flowers   Myrtaceae                   *Psidium*           *densicomum*               5,000 \< MIC \< 12,500
  352                                               IBS 9                 25/06/1998     Stem                 Fabaceae Mimosoideae        *Stryphnodendron*   *pulcherrimum*             2,500 \< MIC \< 5,000
  429                                               PSC 144               30/05/1997     Stem                 Proteaceae                  *Roupala*           sp.                        7,500 \< MIC \< 12,500
  841                                               AAO 3458              26/08/1999     Aerial organs        Myrsinaceae                 *Rapanea*           *parvifolia*               200 \< MIC \< 300
  1247                                              IBS 53                30/09/2001     Aerial organs        Myrtaceae                   *Psidium*           *densicomum*               5,000 \< MIC \< 12,500
  1257                                              AAO 3717              10/08/2001     Aerial organs        Clusiaceae                  *Symphonia*         *globulifera*              200 \< MIC \< 300
  1259                                              IBS 56                30/09/2001     Aerial organs        Piperaceae                  *Piper*             sp.                        7,500 \< MIC \< 12,500
  1298                                              AAO 3721              11/08/2001     Stem                 Lauraceae                   *Ocotea*            *myriantha*                300 \< MIC \< 600
  1373                                              IBS 110               06/12/2001     Leaves               Clusiaceae                  *Garcinia*          cf*. macrophylla*          \> 12,500
  1389                                              IBS 142               08/12/2001     Stem                 Clusiaceae                  *Moronobea*         *coccinea*                 1,300 \< MIC \< 2,500
  1395                                              IBS 143               08/12/2001     Leaves               Fabaceae Caesalpinioideae   *Hymenaea*          *parvifolia*               80 \< MIC \< 200
  1461                                              AAO 4015              12/05/2002     Aerial organs        Sapindaceae                 *Paullinia*         cf*. alata*                7,500 \< MIC \< 12,500
  1493                                              AAO 4031              13/05/2002     Aerial organs        Convolvulaceae              *Ipomoea*           *alba*                     \< 40
  1497                                              IBS 164               13/06/2002     Aerial organs        Moraceae                    *Sorocea*           *duckei*                   200 \< MIC \< 300
  1525                                              IBS 63                01/11/2001     Stem                 Connaraceae                 *Connarus*          *ruber var. ruber*         600 \< MIC \< 1,300
  1543                                              AAO 3711              10/08/2001     Aerial organs        Clusiaceae                  *Tovomita*          *longifolia*               \> 12,500
  1549                                              AAO 4027              12/05/2002     Aerial organs        Combretaceae                *Combretum*         *rotundifolium*            200
  1637                                              AAO 4120              20/07/2002     Aerial organs        Annonaceae                  *Diclinanona*       *calycina*                 ≤ 40
  1743                                              IBS 204               12/07/2003     Aerial organs        Connaraceae                 *Connarus*          cf*. ruber var. sprucei*   1,300 \< MIC \< 2,500
  1765                                              IBS 142               08/12/2001     Flores               Clusiaceae                  *Moronobea*         *coccinea*                 40 \< MIC \< 80
  1905                                              AAO 4148              21/07/2002     Stem                 Clusiaceae                  *Symphonia*         *globulifera*              2,500 \< MIC \< 5,000
  1923                                              AAO 4029              12/05/2002     Aerial organs        Fabaceae Faboideae          *Vatairea*          *guianensis*               2,500 \< MIC \< 5,000
  1991                                              AAO 4148              21/07/2002     Aerial organs        Clusiaceae                  *Symphonia*         *globulifera*              80 \< MIC \< 200
  1999                                              AAO 4199              22/08/2002     Aerial organs        Myristicaceae               *Iryanthera*        *laevis*                   \> 12,500

Odd numbers refer to organic extracts and even numbers refer to aqueous extracts.

MIC = minimal inhibitory concentration obtained from microdilution broth assay.

### Enteroroccus faecalis

The biosafety level 2 bacteria used in all assays were obtained from ATCC. Bacteria was acquired lyophilized, in Loops^®^ (Oxoid Ltd, London, England), and was seeded in Müeller-Hinton agar (Oxoid Ltd, London, England), put in an incubator for 24 h, at 36 °C. this plate was called "mother-plate", and was left to be used within 30 days, if kept under refrigeration. 24-h fresh colonies were acquired before each assay, so, bacteria were at the same 4^th^ passage during every experiment performed in the present work.

Disk diffusion assay and the determination of the growth inhibition zone diameter
---------------------------------------------------------------------------------

Disk diffusion assay was done as usually described for plant extracts analysis ([@B33]), in strict sterile conditions. A 0.5 McFarland saline suspension was prepared from a fresh colony of *Enterococcus faecalis* ATCC^®^ 29212™. Assay was performed in sterile Müeller-Hinton agar prepared in Petri dishes. Sterile swabs were used to seed bacteria on the medium surface. Six paper disks measuring 6 mm diameter were distributed over inoculated medium surface. Then, 10 μL of extracts and residues were added to each disk, in triplicate. Dishes were incubated at 36 °C for 24 h. After that, the diameters of growth inhibition zones were measured horizontally and vertically with a caliper rule.

Statistical analysis for disk diffusion assays
----------------------------------------------

One-way ANOVA and Tukey's post-test analysis was applied in the evaluation of growth inhibition zone diameters resulted from the antibacterial activity of plant extracts and their residues, SH1%F = formulated sodium hypochlorite 1%; SH1%C = commercial sodium hypochlorite 1% (standard drugs used as positive control), against *Enterococcus faecalis* ATCC^®^ 29212™. Results were significant if p \< 0.05.

Microdilution broth assay and determination of minimal inhibitory concentration and minimal bactericidal concentration
----------------------------------------------------------------------------------------------------------------------

The extracts were tested by the microdilution broth assay (MDBA), in completely sterile conditions, adapted to high-throughput conditions ([@B38]), in a biosafety level 2 Laboratory Unit, using sterilized Müeller-Hinton broth medium (Oxoid Ltd, London, England), in 96-well microplates, with inocula adjusted to a 0.5 McFarland standard, or 1 × 10^8^ colony-forming unit per mL (cfu/mL), obtained from fresh colonies of *Enterococcus faecalis* ATCC^®^ 29212™ ([@B37]; [@B38]; [@B36]) grown on sterilized Müeller-Hinton agar medium (Oxoid Ltd, London, England). Concentrations of bacterial suspension, such as 1 × 10^2^, 1 × 10^3^, 1 × 10^4^, 1 × 10^5^, 1 × 10^6^, and 1 × 10^7^ cfu/mL, were prepared in sterilized Müeller -Hinton broth medium (Oxoid Ltd, London, England) starting from the 1 × 10^8^ colony-forming unit per mL (cfu/mL) suspension. Thus, a 190-μL aliquot of the inoculum was dispensed into the wells, and 10 μL aliquots of extract, residue or standard compound solutions were then added to the inoculum. Microplates were incubated at 37 °C for 24 h. Inhibition of bacterial growth was assessed visually, and bacterial suspensions from all test wells were subcultured in sterile agar medium in order to evaluate bactericidal activity.

Following a procedure similar to that described above in sterile MDBA, minimal inhibitory concentration (MIC) and minimal bactericidal concentration (MBC) were obtained for the 25 plant extracts (PE), against *E. faecalis*. Solvent dimethylsulfoxide were tested as negative control.

Liquid-liquid partition and biological assay of residues
--------------------------------------------------------

Each one of the 25 extracts was partitioned with three solvents of different polarities resulting in non polar residues (chloroform residue, or Residue CHCl~3~, or EB-CHCl~3~ where EB refers to the extract number), intermediate-polarity residues (butanol residue, or Residue BuOH, or EB-BuOH where EB refers to the extract number), and polar residues (aqueous residue, or Residue H~2~O, or EB-H~2~O where EB refers to the extract number). The solvents were completely evaporated, followed by lyophilization, resulting in 75 residues. Organic solvents were completely removed under vacuum. All residues were re-suspended in 50% dimethylsulfoxide (DMSO50) or in distilled water (both tested as negative controls), at the concentration of 200 mg/mL, to be tested, as follows.

For preparation of 200 mg/mL solutions, aqueous residues were diluted with Milli-Q distilled water (Millipore^®^, Bedford, MA, USA) and chloroform and butanol residues were diluted in DMSO50, in order to be assayed by the MDBA, according to the technique previously described, in bacterial suspensions containing 1 × 10^6^ cfu/mL.

Thin-layer chromatography
-------------------------

Thin-layer chromatography (TLC) was performed with extracts and residues. Silica gel GF chromatography sheets (Merck^®^, Whitehouse Station, New Jersey, USA) were used and the following mobile phase were prepared: System 1 - hexane and ethyl acetate (4:1) applied on chromatographic sheet 1; System 2 - chloroform and ethyl acetate (1:1) applied on chromatographic sheet 2; and System 3 - chloroform, ethyl acetate and methanol (2:2:1); System 4 - ethyl acetate, methanol and water (100:13.5:10); System 5 - ethyl acetate, glacial acetic acid, formic acid and water (100:11:11:26). Revelation of spots was done with potassium hydroxide (A); Kedde Reagent (B), Dragendorff Reagent (C), NP Reagent (D), 25% sulfuric acid solution (E) and β-caroten (F). Ultraviolet light at 254 and/or 366 nm (uv254 or uv356) was used to develop some of the chromatograms ([@B36]).

Evaluation of antioxidant potential
-----------------------------------

Evaluation of the antioxidant potential of extracts and residues was performed using the β-carotene technique ([@B31]), in System 3 described above. A mixture of two solutions composed of (a) 9-mg β-carotene dissolved in 30 mL of chloroform and (b) two drops of linoleic acid dissolved in 60 mL of ethanol was used to reveal antioxidant substances in chromatogram. The chromatograms were exposed to natural light for at least 2 h in order to catalyze the antioxidant reaction between the natural product and the development system.

Fractionation of EB 1257
------------------------

Extract EB1257, obtained from the aerial organs of *S. globulifera*, was used in the chemical assays.

### Column chromatography fractionation

In order to isolate major compounds, 16.7668 g of extract 1257 were submitted to liquid-liquid partition using the technique first described, which resulted in Residue CHCl~3~ (7212.6 mg, or 43.02% yield) Residue BuOH (3815.3 mg, or 22.76% yield) and Residue H~2~O (5738.9 mg, or 34.23% yield). Residue CHCl~3~ was submitted to open CC fractionation with Sephadex LH-20 as stationary phase, and 100% hexane, 100% dichloromethane and 100% methanol, as mobile phase, and resulted in hexane fraction (3031.2 mg, or 42.03% yield), dichloromethane fraction (1230.9, or 17.07% yield mg) and methanol fraction (2950.5 mg, or 40.91% yield).

### Chromatographic techniques used in the isolation of major compounds - thin layer chromatography and normal phase open column chromatography

The hexane fraction obtained from Residue CHCl~3~, which was obtained from EB1257, was submitted to fractionation in column chromatography using silica gel 60--200 μm as stationary phase and a gradient with increasing polarity composed by mixtures of hexane, ethyl acetate and methanol as mobile phase, which resulted in 28 fractions. The fractions were compared by TLC and were grouped according to their similarity, after analysis with sulfuric acid 25% and heating, resulting in fractions 10--11, 12, 13, 14--15, 16, 17,.., 28. Fraction 13, named UNIP147 was sent to ^1^H NMR and e ^13^C NMR, in CDCl~3~.

Fraction 13 (or UNIP147) was obtained as a crystal cream sample (30 mg). ^1^H NMR was obtained but it showed to be complex. So, a ^13^C NMR was obtained in order to support molecules' identification. Three molecules were identified and their spectra were compared to that in the literature.

Results
=======

Taxonomic information of the 25 plants included in the present study is provided in [Table 1](#t01){ref-type="table"} and extracts are referred to in the text by their extract number.

[Figure 1](#f01){ref-type="fig"} represents the comparison among means obtained from inhibition growth zone diameters of the extracts and positive / negative controls, in the disk diffusion assay against 0.5 McFarland inoculum of *E. faecalis*. One-way ANOVA followed by Tukey's post-test indicated that the means were significant different (F~(26,\ 135)~ = 32.06; p \< 0.0001; *R*^2^ = 0.8606, 27 groups). Results generated from both DMSO solutions (media = 0.00 mm growth inhibition zone diameters) were not included in statistical analysis due to the lack of homocedasticity if those groups were included. The following treatments showed to be as efficient as SH1%F (p \> 0.05): 55.PE, 352.PE, 841.PE, 1247.PE, 1257.PE, 1298.PE, 1373.PE, 1389.PE, 1497.PE, 1549.PE, 1743.PE, 1765.PE, 1905.PE, 1923.PE, 1999.PE. The following treatments showed to be significantly more efficient than SH1%F (p \< 0.05): 1493.PE, 1525.PE and 1991.PE. Considering SH1%C, the following treatments showed equivalent antibacterial activity (p \> 0.05): 1257.PE, 1298.PE, 1389.PE, 1497.PE, 1525.PE and 1999.PE.Lastly, the following treatments were significantly more efficient than SH1%C (p \< 0.05): 1493.PE 1991.PE.

![Two-way ANOVA and Bonferroni's post-test analysis related to growth inhibition zone diameters obtained from the antibacterial activity in disk diffusion assay of plant extracts and their chloroform, buthanol and aqueous residues (concentration of 200 mg/mL), formulated and commercial sodium hypochloride 1% (used as positive controls) and dimethylsulfoxide 50% and pure (used as negative control), against *Enterococcus faecalis* ATCC^®^ 29212™. SH1%F = formulated sodium hypochlorite 1%; SH1%C = commercial sodium hypochlorite 1%. Residues are nominated as XX.CHCL3, XX.BuOH, XX.H2O and XX.PE, where XX corresponds to the extract number. Significance were considered if p \< 0.05.](bjm-45-769-g001){#f01}

[Figure 2](#f02){ref-type="fig"} represents the comparison among means obtained from inhibition growth zone diameters of the extracts, residues and standard drugs, in the disk diffusion assay against 0.5 McFarland inoculum of *E. faecalis* using one-way ANOVA followed by Tukey's post-test. Results generated from both DMSO solutions (mean = 0.00 mm growth inhibition zone diameters) were not included in statistical analysis due to the lack of homocedasticity if those groups were included. The following treatments showed to be as efficient as SH1%F (p \> 0.05): 55.BuOH, 321.BuOH, 352.BuOH, 1257.CHCl~3~, 1257.Aq, 1389.Aq, 1525.Aq and 1991.CHCl~3~. The following treatments were more effective than SH1%F (p \< 0.05): 321.Aq, 352.Aq, 841.BuOH, 1257.BuOH, 1259.BuOH, 1298.BuOH, 1389.BuOH, 1493.CHCl~3~, 1493.BuOH, 1525.BuOH and 1991.BuOH. In relation to SH1% C, the following treatments were statistically equivalent antibacterial activity (p \> 0.05): 55.BuOH, 352.BuOH, 841.BuOH, 1257.BuOH, 1259.BuOH, 1298.BuOH, 1389.BuOH, 1525.BuOH and 1991.CHCl~3~. Finally, the following treatments were more effective than SH1%C (p \< 0.05): 321.Aq, 352.Aq, 1493.CHCl~3~, 1493.BuOH and 1991.BuOH.

![One-way ANOVA and Tukey's post-test analysis related to growth inhibition zone diameters obtained from the antibacterial activity in disk diffusion assay of plant extracts, residues (concentration of 200 mg/mL), formulated and commercial sodium hypochloride 1% (used as positive controls), against *Enterococcus faecalis* ATCC^®^ 29212™. SH1%F = formulated sodium hypochlorite 1%; SH1%C = commercial sodium hypochlorite 1%. Significance were considered if p \< 0.05.](bjm-45-769-g002){#f02}

[Table 2](#t02){ref-type="table"} shows the antioxidant activity of residues. Antioxidant compounds are prone to be found in residues BuOH obtained from extracts EB 55, EB 841, EB 1257, EB 1373, EB 1389, EB 1525, EB 1905, EB 1991 and EB 1999. Also, antioxidant compounds are prone to be found in residues CHCl~3~ obtained from extract EB 1637 and in residues H~2~O obtained from extracts EB 1525 and EB 1905.

###### 

Results corresponding to the antioxidant activity of residues, which represent reaction to β-caroten.

  Extract number   CHCl~3~   BuOH   H~2~O
  ---------------- --------- ------ -------
  55               \-        X      \-
  321              \-        \-     \-
  352              \-        \-     \-
  429              \-        \-     \-
  841              \-        X      \-
  1247             \-        \-     \-
  1257             \-        X      \-
  1259             \-        \-     \-
  1298             \-        \-     \-
  1373             \-        X      \-
  1389             \-        X      \-
  1395             \-        \-     \-
  1461             \-        \-     \-
  1493             \-        \-     \-
  1497             \-        \-     \-
  1525             \-        X      X
  1543             \-        \-     \-
  1549             \-        \-     \-
  1637             X         \-     \-
  1743             \-        \-     \-
  1765             \-        \-     \-
  1905             \-        X      X
  1923             \-        \-     \-
  1991             \-        X      \-
  1999             \-        X      \-

CHCl~3~ = chloroformic residue; BuOH = butanolic residue; H~2~O = aqueous residue; H = horizontal; V = vertical. (-) = not antioxidant; X = antioxidant.

TLC analysis of EB 321, EB 352, EB 1257, EB 1493, EB 1525, EB 1765, EB 1991 and EB 321 indicated that phenolic compounds might be present, once a weak blue fluorescence could be seen after NP and uv356 development. Triterpenes or essential oils (due to sulfuric acid development) may be present in EB 321. EB 352 may also have phenolic compounds (due to the yellow spots that could be seen after NP and uv356 development) and triterpenes or essential oils. EB 1257 may have coumarins or anthrone-like compounds, once the development with KOH showed a brown spot under visible light, and may have phenolic compounds related to orange spots observed after NP and uv 356 development. Triterpenes may also be present in this extract. EB1493 may have triterpenes as major compounds, once only the sulfuric acid solution revealed the the chromatogram. EB 1525 may have coumarins and triterpenes. EB 1765 may have antrone-like compounds (development under KOH and visible light), a brown spot was observed after development with Dragendorff's Reagent and NP followed by uv356 observation showed two orange and one yellow-green spots, suggesting the presence of phenolic compounds. Lastly, EB 1991 showed a yellow spot after development with KOH, suggesting anthrone-like compounds, 3 orange and 1 yellow-green spot, after development with NP and uv356.

EB 1257 was fractionated and compounds lupeol, β-amyrin and 3β-hydroxyglutin-5-ene were isolated ([Figure 3](#f03){ref-type="fig"}) and their structure was identified by ^13^C NMR (125 MHz, CDCl~3~) analysis and comparison with literature ([Table 3](#t03){ref-type="table"}).

![Molecular structure of UNIP-147 isolated compounds (A) lupeol, (B) β-amyrin and (C) 3β-hydroxyglutin-5-ene.](bjm-45-769-g003){#f03}

###### 

^13^C NMR (125 MHz, CDCl~3~) data for sample UNIP-147.

  Carbon                    δ (ppm)                     
  -------- ------- -------- --------- -------- -------- --------
  1        38.7    38.72    38.7      38.6     18.3     18.22
  2        27.4    27.46    27.3      27.38    27.93    27.98
  3        78.9    79.04    79        79.02    76.44    76.37
  4        38.8    38.93    38.8      38.86    40.90    40.84
  5        55.3    55.30    55.3      55.19    141.76   141.61
  6        18.3    18.32    18.5      18.42    122.10   122.05
  7        34.2    34.29    32.8      32.78    23.74    23.54
  8        40.8    40.80    38.8      38.96    47.55    47.24
  9        50.4    50.45    47.7      47.64    34.94    34.84
  10       37.1    37.17    37.6      37.84    49.83    49.69
  11       20.9    20.94    23.6      23.64    33.24    33.12
  12       25.1    25.15    121.8     121.74   30.45    30.36
  13       38      38.07    145.1     145.19   37.95    37.84
  14       42.8    42.84    41.8      41.72    39.40    39.30
  15       27.4    26.95    26.2      26.16    34.72    34.61
  16       35.5    35.59    27        27.19    35.19    35.25
  17       43      43.01    32.5      32.49    30.18    30.09
  18       48.2    48.32    47.4      47.43    43.21    43.07
  19       47.9    47.99    46.9      46.84    35.19    35.08
  20       150.9   150.96   31.1      31.09    28.32    28.14
  21       29.8    29.69    34.8      34.75    32.2     32.08
  22       40      40.01    37.2      37.29    30.05    29.85
  23       28.0    28.06    28.2      28.25    29.04    28.97
  24       15.4    15.39    15.5      15.55    25.51    25.45
  25       16.1    16.12    15.6      15.61    16.26    16.21
  26       15.9    15.94    16.9      16.82    18.47    18.39
  27       14.5    14.57    26        26.00    19.69    19.62
  28       18      18.01    28.4      28.41    32.46    32.41
  29       109.3   109.34   33.3      33.35    32.12    32.05
  30       19.3    19.31    23.7      23.71    34.6     34.53

Discussion
==========

*E. faecalis* is an important pathogen related to diseases that affect the oral cavity. In endodontic infections, especially in recurrent infection, its presence is commonly associated with treatment failure ([@B17]; [@B05]). SH is a compound of choice in Dentistry, and is widely used in different concentrations, in Endodontics. Nonetheless, the compound has undesirable effects, which are often disregarded when these substances are elected because of their antimicrobial therapeutic benefit. Therefore, substances that have similar therapeutic efficacy and fewer side effects should be tracked and used in dental therapy. Natural products, such as propolis ([@B17]), are being investigated for their antibacterial activity.

Two experimental models were selected to evaluate the potential antimicrobial activity of plant extracts against *E. faecalis*: DDA and MDBA, understanding that both together might contribute to the prospection of new lead compounds in a complementary way. It is not the scope of the present manuscript to determine which assay is more suitable to be used - and discussions on the subject have widely been made before ([@B05]). Briefly, natural products are complex mixture of substances that have different physical-chemical characteristics. Such differences may interfere with the characteristics of each DDA or MDBA assay due to the way chemicals can diffuse (in DDA) or dilute (in MDBA) in each type of medium. The use of both experiments seems to be complementary so far.

Based on analyses done with extracts in MDBA ([Table 1](#t01){ref-type="table"}) - which compared data from various concentrations of treatments tested against bacterial concentration of 1.0 × 10e5 CFU/mL, it was possible to identify three promising extracts: EB 1493, EB 1637 and EB 1765. EB 1493 was obtained from aerial organs of *Ipomoea alba* L. (Convolvulaceae). *I. alba* was barely studied in terms of its chemical constituents or pharmacological activity. The use of its latex was reported ([@B12]). Sweet potato is one of the species belonging to *Ipomoea* genus. Clavine alkaloids occur in *I. muricata* ([@B22]), as well as ipobscurines that are indol alkaloids from the macrolactam-type ([@B14]) and alkaloids occur in some toxic species, as in *I. carnea* ([@B10]). Other compounds as anthocyanins ([@B34]) and polyphenolic compounds ([@B19]) also occur in *Ipomoea* species.

Extract 1637, obtained from *Diclinanona calycina* (Annonaceae), has shown a significant activity in the assay. Previous study made with *D. calycina*, tested against diverse microorganisms in an agar-diffusion model, has shown its activity against *Streptococcus oralis* and *Mycobacterium smegmatis* ([@B04]). Annonaceae species were chemically studied before. Alkaloids ([@B28]) and acetogenins ([@B23]) are the main classes of active compounds occurring in the family.

Extract EB 1765 was obtained from the flowers of *Moronobea coccinea*, a species belonging to Clusiaceae. Polycyclic polyprenylated acylphoroglucinols and oxidized derivatives ([@B21]) were isolated from *M. coccinea*, as well as xanthone derivatives and flavonoids ([@B24]).

DDA showed a different group of active extracts: EB 1257, EB 1493, EB 1525 and EB 1991. Extracts 1257 and 1991 were obtained from aerial organs of *S. globulifera*, Clusiaceae in different periods of time. Chemistry of *Ipomoea* (EB 1493) species was previously discussed. Extract 1525 was obtained from the stem of *Connarus ruber* var. *ruber* (Connaraceae). It was observed that there is a lack of chemical data related to the genus *Connarus*. Extracts EB 1257 and EB 1991 were obtained from the same species, *S. globulifera*, Clusiaceae, but plants were collected in different periods of time. Reports relate biological activity maybe related to the presence of polycyclic polyprenylated acylphoroglucinols and oxidized derivatives ([@B21]). Xanthones are also present in the species ([@B25]). Chemical studies were performed with EB 1257 due to extract availability. So, isolation and identification of major compounds were performed and resulted in lupeol, α-amyrin and 3β-hydroxyglutin-5-ene as isolated compounds, widely known for their biological and pharmacological activities.

All 25 extracts were submitted to an initial fractionation, resulting in three residues to each extracts: CHCl~3~, BuOH and H~2~O. It was observed that after extracts 321 and 352 were fractionated, a significant improvement of the antibacterial activity could be observed in their H~2~O residue. For that reason, both extracts were also chosen to be studied in a near future. Extract 321, obtained from the leaves of *Psidium densicomum* (Myrtaceae), belongs to a group of plants (guajava family) well known to contain terpenes, triterpenoids and flavonoids ([@B11]; [@B08]). Extract 352 was obtained from aerial parts of *Stryphnodendron pulcherrimum* (Fabaceae), species taxonomically related to a medicinal plant known in Brazil as *barbatimao*, that was already studied against oral pathogens ([@B27]) to contain tannins as the main chemical class of compounds ([@B32]).

As fractionation of the 25 extracts was done exactly in the same way to obtain residues, added to the fact that all residues were tested at the same time, in both biological assays, it is possible to suggest a comparative analysis based on the results obtained from the biological assays of residues. Antibacterial results obtained from the residues when compared to their original extracts may take different courses: (a) biological activity has been missing during fractionation, and synergism was lost; (b) biological activity is concentrated in one fraction and its antibacterial activity may be improved or not, in relation to the original extract; (c) biological activity appears in two or more fractions and the antibacterial activity may have improved or not, in relation to the original extract. Based on that premises, a large number of extracts can be considered for further analyses, which is profitable but time-consuming. For that reason, it is primordial to establish a method according to which the extracts and their residues are going to be compared among each other, and the more adequate way is to rank MIC's and MBC's values of treatments when MDBA is used, and to compare growth inhibition zones of treatments by analysis of variance ANOVA, as applied in the present work when DDA is used. If that idea is applied, it is possible to create a ranking establishing which extract and/or residue is best to be prioritized in the studies.

As the current study aims the identification of a new compound to be used in root canal treatment, it is important to compare the efficacy of extracts treatments to SH, which is one of the compounds of choice, for this application. SH was prepared at the concentration of 1% to be used as standard drug, despite its wide range of concentrations found in literature, ranging from 1 to 5.25% that are available in the marketing. Studies reporting the efficacy of SH in biofilms obtained from *E. faecalis* and/or *S. mutans* were done and this compound showed better efficacy when used against biofilms obtained from planktonic cultures ([@B15]). Although a direct comparison between SH and plant extracts is not feasible, since SH is an isolated compound and plant extracts are highly complex mixtures of compounds of various origins, the results obtained for SH provide an important reference for a comparative, albeit indirect, analysis of the antibacterial activity of extracts. Moreover, it is highly expected that when active substances are isolated from the extracts, they may become more active than the original extract, which is going to be further done.

Antioxidant activity was also evaluated, and resulted that 55.BuOH, 841.BuOH, 1257.BuOH, 1373.BuOH, 1389.BuOH, 1525.BuOH, 1525.H~2~O, 1637.CHCl~3~, 1905.BuOH, 1905.H~2~O, 1991.BuOH, 1999.BuOH showed activity in the β-caroten TLC assay. Further evaluation of isolated compounds shall be done in the near future. Chemical data found in the literature is consistent with results we obtained in the TLC analysis of the main chemical classes as phenolic compounds, triterpenes and alkaloids, and will support future isolation procedures to be done with all seven active extracts.

Results related to the efficacy of the extracts against planktonic cultures do not assure that the extracts are going to be as effective against biofilms, and for that reason, further *in vitro* studies regarding the activity of extracts against biofilms are being developed today as well as the evaluation of the extracts in toxicological assays, in order to gather information to support *in vivo* studies ([@B03]) with the extracts.

Conclusions
===========

Nature is a potential source of new drugs to be used in Dentistry. In the present work, seven plant extracts obtained from species native to the Amazon rain forest showed significant activity against *E. faecalis* and showed that antioxidant compounds may be present as well, indicating that possibly phenolic compounds may be involved in antibacterial activity. Also, statistical design here proposed also contributes to optimize the decision-making of which extract shall be prioritized for chemical studies so as to isolate active compounds that might be introduced in endodontic therapy.
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